A controlled trial of amlodipine for cocaine dependence: A negative report

Journal of Substance Abuse Treatment

Volumn 28, Issue 2, 2005, Pages 197-204

  Malcolm, Robert ^a,b   LaRowe, Steven ^a   Cochran, Kristi ^a   Moak, Darlene ^a   Herron, Janice ^a   Brady, Kathleen ^a   Hedden, Sarra ^b   Woolson, Robert ^b   Halushka, Perry ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Amlodipine; Cocaine; Double blind trial

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; RIBOFLAVIN;

ADULT; ARTICLE; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; MALE; MUSCULOSKELETAL DISEASE; NEUROTOXICITY; OTORHINOLARYNGOLOGY; PATIENT COMPLIANCE; PERIPHERAL EDEMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; WITHDRAWAL SYNDROME;

EID: 15044354561     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2004.12.006     Document Type: Article

References (24)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed. 1994 Author Washington, DC
2. S.L. Batki, J. Moon, K. Delucchi, D. Hersh, M. Bradley, C. Aguillon-Doms, J. Mendelson, R.T. Jones, T. Panganiban, T. Everhart, M. Mengis, S. Smolar, H. Helmke, and P. Jacob III Amlodipine treatment of methamphetamine dependence, a controlled outpatient trial: Preliminary analysis Drug & Alcohol Dependence 63 Suppl 1 2001 12
3. A. Bourson, A.J. Gower, A.K. Mir, and P.C. Moser The effects of dihydropyridine compounds in behavioural tests of dopaminergic activity British Journal of Pharmacology 98 1989 1312 1318
4. R. Burges, and D. Moisey Unique pharmacologic properties of amlodipine American Journal of Cardiology 73 1994 2A 9A
5. D.J. Calcagnetti, B.J. Keck, L.A. Quatrella, and M.D. Schechter Blockade of cocaine-induced conditioned place preference: Relevance to cocaine abuse therapeutics Life Sciences 56 1995 474 483
6. K.M. Carroll, B.J. Rounsaville, and D.S. Keller Relapse prevention strategies for the treatment of cocaine abuse American Journal of Drug and Alcohol Abuse 17 1991 249 265
7. G.A. Clavijo, I.V. Clavijo, and C.W. Weart Amlodipine: A new calcium antagonist American Journal of Hospital Pharmacy 51 1994 59 68
8. K.A. Cunningham, and P.M. Callahan The stimulus properties of cocaine: Effects of BAY K 8644 and nimodipine NIDA Research Monograph 95 1989 500 501
9. J.D. Dawson Stratification of summary statistic tests according to missing data patterns Statistics in Medicine 13 1994 1853 1863
10. B. Johnson, L. Lamki, B. Fang, B. Barron, L. Wagner, L. Wells, P. Kenny, D. Overton, S. Dhother, D. Abramson, R. Chen, and L. Kramer Demonstration of dose-dependent global and regional cocaine-induced reductions in brain blood flow using a novel approach to quantitative single photon emission computerized tomography Neuropsychopharmacology 18 1998 377 384
11. H.D. Kleber Pharmacologic treatments for heroin and cocaine dependence American Journal on Addictions 12 2003 S5 S18
12. A.A. Kochegarov Pharmacological modulators of voltage-gated calcium channels and their therapeutical application Cell Calcium 33 2003 145 162
13. G.F. Koob, and M. Le Moal Drug addiction, dysregulation of reward, and allostasis Neuropsychopharmacology 24 2001 97 129
14. D.B. Marin, and K.L. Davis Cognitive enhancers A.F. Schatzberg C.B. Nemeroff American psychiatric press textbook of psychopharmacology 2nd ed. 1998 American Psychiatric Press Washington, DC 473 476
15. D.N. Middlemiss, and M. Spedding A functional correlate for the dihydropyridine binding site in rat brain Nature 314 1985 94 96
16. C. Muntaner, K.M. Kumor, C. Nagoshi, and J.H. Jaffe Effects of nifedipine pretreatment on subjective and cardiovascular responses to intravenous cocaine in humans Psychopharmacologia 105 1991 37 41
17. C.P. O'Brien Research advances in the understanding and treatment of addiction American Journal on Addictions 12 2003 S36 S47
18. L. Pani, A. Kuzmin, M. Diana, G. De Montis, G.L. Gessa, and Z.L. Rossetti Calcium receptor antagonists modify cocaine effects in the central nervous system differently European Journal of Pharmacology 190 1990 217 221
19. L. Pani, A. Kuzmin, M.C. Martellotta, G.L. Gessa, and W. Fratta The calcium antagonist PN 200-110 inhibits the reinforcing properties of cocaine Brain Research Bulletin 26 1991 445 447
20. M. Rosselli, and A. Ardila Cognitive effects of cocaine and polydrug abuse Journal of Clinical and Experimental Neuropsychology 18 1996 122 135
21. T.P. Snutch, K.G. Sutton, and G.W. Zamponi Voltage-dependent calcium channels-beyond dihydropyridine antagonists Current Opinion in Pharmacology 1 2001 11 16
22. M. Sofuoglu, G. Gonzalez, J. Polling, and T.R. Kosten Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence The American Journal of Drug and Alcohol Abuse 29 2003 713 727
23. M. Sofuoglu, A. Singha, T.R. Kosten, F.E. McCance-Katz, I. Petrakis, and A. Oliveto Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans Pharmacology Biochemistry and Behavior 75 2003 801 808
24. H. Vanegas, and H. Schaible Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia Pain 85 2000 9 18